Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eledon Pharmaceuticals
NCT07412470 · Kidney Transplant Rejection
NCT07415876 · Kidney Transplant Rejection
NCT07006532 · Kidney Transplant Rejection
NCT07275541 · Platelet Aggregation, Kidney Transplant Rejection
NCT07060716 · Kidney Transplant Rejection, Cell-free DNA
University of California Los Angeles
Los Angeles, California
Keck School of Medicine of USC
Los Angeles, California
University of California, Irvine Medical Center
Orange, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions